Abstract:The marine natural product pateamine A (1) and its somewhat simplified designer analogue DMDA-Pat A (2) (DMDA = desmethyl-desamino) are potently cytotoxic compounds; most notably, 2 had previously been found to exhibit a promising differential in vivo activity in xenograft melanoma models, even though the ubiquitous eukaryotic initiation factor 4A (eIF4A) constitutes its primary biological target. In addition, 1 had also been identified as a possible lead in the quest for medication against cachexia, an often lethal muscle wasting syndrome affecting many immunocompromised or cancer patients. The short supply of these macrodiolides, however, rendered a more detailed biological assessment difficult. Therefore, a new synthetic approach to 1 and 2 has been devised, which centers on an unorthodox strategy for the formation of the highly isomerization-prone but essential Z, E-configured dienoate substructure embedded into the macrocyclic core. This motif was encoded in the form of a 2-pyrone ring and unveiled only immediately before macrocyclization by an unconventional iron-catalyzed ring opening/cross-coupling reaction, in which the enol ester entity of the pyrone gains the role of a leaving group. Since the required precursor was readily available by gold catalysis, this strategy rendered the overall sequence short, robust, and scalable. A surprisingly easy protecting group management together with a much improved end game for the formation of the trienyl side chain via a modern Stille coupling protocol also helped to make the chosen route practical. Change of a single building block allowed the synthesis to be redirected from the natural lead compound 1 toward its almost equipotent analogue 2. Isolation and reactivity profiling of pyrone tricarbonyliron complexes provide mechanistic information as well as insights into the likely origins of the observed chemoselectivity.

Asymmetric Total Syntheses of (+)-Penostatins A and C

Enantioselective Total Synthesis of (+)-Penostatins A and C.

Enantioselective Total of (+)-Penostatins A and C

Asymmetric synthesis of penostatins A-D from L-ascorbic acid

Total Synthesis of (−)-Penicimutanin a and Related Congeners

Asymmetric Total Syntheses of Hypoestin A, Albolic Acid, and Ceroplastol II

Novel Bioactive Penicipyrroether A and Pyrrospirone J from the Marine-Derived Penicillium Sp. ZZ380.

Enantioselective Total Synthesis of (-)-cephalotanin B.

Asymmetric total synthesis and anti-hepatocellular carcinoma profile of enantiopure euphopilolide and jolkinolide E

Synthetic Studies On Camptothecins Part 1 An Improved Asymmetric Total Synthesis Of (20s)-Camptothecin

Total Synthesis of Dactylicapnosines A and B.

Asymmetric Total Synthesis of Cephalotaxus Diterpenoids: Cephinoid P, Cephafortoid A, 14- epi -Cephafortoid A and Fortalpinoids M-N, P

Synthetic Studies on Camptothecins. Part 1

Atroposelective Total Synthesis of (+)‐Isokotanin A via Combined Metal and Enzyme Catalysis

Total Synthesis of (+)‐3‐deoxyfortalpinoid F, (+)‐fortalpinoid A, and (+)‐cephinoid H

Asymmetric cinnamylation of N-tert-butanesulfinyl imines with cinnamyl acetates: total syntheses of (+)-lycoricidine and (+)-7-deoxypancratistatin.

Total Synthesis of (+)-Peniciketal B

Enantioselective formal total synthesis of dihydrospirotryprostatin B

Catalytic Asymmetric Total Synthesis of Hedyosumins A, B, and C

Catalysis-Based Total Syntheses of Pateamine A and DMDA-Pat A.

Total synthesis of 1,4a-di-epi-ent-pancratistatin, exemplifying a stereodivergent approach to pancratistatin isomers